Article Text

Download PDFPDF
Prevention and treatment system of novel coronavirus infection in medical and health institutions: experience in West China Hospital of Sichuan University
  1. Qiao Zhou1,
  2. He Yu1,
  3. Zong-An Liang1,
  4. Rong Yao2,
  5. Feng-Ming Luo1,
  6. Dan Liu1,
  7. Ting Wang1,
  8. Zhong Ni1,
  9. Ce-Jun Zhong3,
  10. Xiao-Dong Jin4
  1. 1 Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China
  2. 2 Emergency Department, West China Hospital of Sichuan University, Chengdu, Sichuan, China
  3. 3 Infectious Disease Department, West China Hospital of Sichuan University, Chengdu, Sichuan, China
  4. 4 Department of Intensive Care Unit, West China Hospital of Sichuan University, Chengdu, Sichuan, China
  1. Correspondence to Dr Zong-An Liang, West China Hospital of Sichuan University, Chengdu, Sichuan, China; liangza{at}scu.edu.cn

Abstract

The novel coronavirus infection broke out in Wuhan, China, in December 2019, and progressed to a global pandemic. We describe the measures taken by West China Hospital of Sichuan University to address the diagnosis, prevention and treatment of the infection.

  • clinical management
  • emergency care systems
  • epidemiology
  • infectious diseases, viral

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • QZ and HY are joint first authors.

  • Handling editor Edward Carlton

  • QZ and HY contributed equally.

  • Contributors QZ and HY contributed equally to this work and are co-first authors. Z-AL is the corresponding author. Other authors had experience of resisting COVID-19 infection. ZQ and YH contributed equally to this work and should be considered co-first authors Z-AL is the correspondence author of this review. Other authors have self-experience in resisting novel coronavirus infection.

  • Funding This work was supported by the Novel Coronavirus Emergency Projects of Sichuan Science and Technology Office (grant No 2020YFS0005, grant No 2020YFS0009).

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.